Access with Evidence Development
Health Technology Assessment International (HTAi) is host of the Interest Sub-Group on Conditional Coverage/Access with Evidence Development. The scope of this group may broaden to include other forms of conditional reimbursement, such as risk sharing schemes, and appropriate breadth of focus for this ISG will be one of the issues about which we will seek feedback from the group in the near future.
This online network has been created so that we may share documents and information as they are developed. We are aware that many have done a substantial amount of work on these issues already, and our hope is that this group can serve as a common forum for sharing and advancing work in this topic area.
Health Technology Assessment International
HTAi is the global scientific and professional society for all those who produce, use, or encounter HTA. HTAi embraces all stakeholders, including researchers, agencies, policymakers, industry, academia, health service providers, and patients/consumers, and acts as a neutral forum for collaboration and the sharing of information and expertise. With members from 59 countries and six continents, HTAi is a thriving global network.
HTAi is actively committed to international collaboration, and has signed formal Memoranda of Understanding with the World Health Organization, the International Society for Quality in Health Care (ISQua), and the International Network of Agencies for HTA (INAHTA).
Center for Medical Technology Policy
The Center for Medical Technology Policy (CMTP) is an independent nonprofit dedicated to developing a health care system where patients, clinicians, health care policymakers, and payers have the evidence they need to make informed health decisions. We convene and collaborate with a national and international network of thought leaders, patients, patient advocates, clinicians, policymakers, and payers. Together, we support the next generation of clinical research. We do this by providing methodological guidance, shaping health policy solutions, and transforming clinical research.
With funding from government, industry, and foundations, CMTP breaks down traditional silos that too often divide researchers and the clinical research enterprise from patients and the real-world health care questions that need answering. In an environment of increasing cost pressures, we are experts in bringing together diverse perspectives to create evidence that leads to better health care, while sustaining meaningful innovation.